# 59572-102-01 · Azacitidine Injection · Bristol Myers Squibb Co. — FDA drug shortage duration tracker

For 59572-102-01 · Azacitidine Injection · Bristol Myers Squibb Co., package ndc is 59572-102-01; generic name is Azacitidine Injection; manufacturer is Bristol Myers Squibb Co; status is Current; availability now is Available, recorded from its source on 2026-09-01; source re-checked 2026-09-16.

- **Package NDC:** 59572-102-01 _(verified: appears in the quote below)_
- **Generic name:** Azacitidine Injection _(verified: appears in the quote below)_
- **Manufacturer:** Bristol Myers Squibb Co. _(verified: appears in its own passage below)_
- **Status:** Current _(verified: appears in its own passage below)_
- **Availability now:** Available _(verified: appears in the quote below)_
- **Initial posting date:** 12/18/2020 _(verified: appears in the quote below)_
- **Last update date:** 08/16/2026 _(verified: appears in its own passage below)_
- **Days in shortage:** 2083 _(our reading, not quoted from the source)_
- **Dosage form:** Injection _(verified: appears in its own passage below)_
- **Therapeutic category:** Oncology _(verified: appears in its own passage below)_

## What the source says

> "initial_posting_date": "12/18/2020", "package_ndc": "59572-102-01", "generic_name": "Azacitidine Injection", "contact_info": "1-888-423-5436", "availability": "Available"

## Where each value comes from

This source states these in separate places, so each value is shown with the passage that states it.

### Manufacturer

> "update_date": "08/16/2026", "therapeutic_category": [ "Oncology" ], "dosage_form": "Injection", "presentation": "Vidaza, Injection, 100 mg (NDC 59572-102-01)", "company_name": "Bristol Myers Squibb Co.", "status": "Current"

### Status

> "update_date": "08/16/2026", "therapeutic_category": [ "Oncology" ], "dosage_form": "Injection", "presentation": "Vidaza, Injection, 100 mg (NDC 59572-102-01)", "company_name": "Bristol Myers Squibb Co.", "status": "Current"

### Last update date

> "update_date": "08/16/2026", "therapeutic_category": [ "Oncology" ], "dosage_form": "Injection", "presentation": "Vidaza, Injection, 100 mg (NDC 59572-102-01)", "company_name": "Bristol Myers Squibb Co.", "status": "Current"

### Dosage form

> "update_date": "08/16/2026", "therapeutic_category": [ "Oncology" ], "dosage_form": "Injection", "presentation": "Vidaza, Injection, 100 mg (NDC 59572-102-01)", "company_name": "Bristol Myers Squibb Co.", "status": "Current"

### Therapeutic category

> "update_date": "08/16/2026", "therapeutic_category": [ "Oncology" ], "dosage_form": "Injection", "presentation": "Vidaza, Injection, 100 mg (NDC 59572-102-01)", "company_name": "Bristol Myers Squibb Co.", "status": "Current"

## Source

- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Bristol%20Myers%20Squibb%20Co.%22+AND+generic_name%3A%22Azacitidine%20Injection%22+AND+status%3A%22Current%22&limit=1000

Last verified: 2026-09-16. Review by: 2026-09-19.
Part of [FDA drug shortage duration tracker](https://referencesource.org/drug-shortage-duration-tracker/).